Colin Stott

Chief Operating Officer at ALTEROLA BIOTECH, INC.

Net worth: 173 850 $ as of 31/05/2026

59 year

30 connections

Health Technology

Process Industries

Consumer Services

Profile

Colin G.
Stott is the founder of Phytotherapeutix Holdings Ltd., founded in 2020, serving as Chief Executive Officer.
Mr. Stott is the founder of Phytotherapeutix Ltd., founded in 2019, serving as Chief Executive Officer.
Current jobs include Independent Director at Cardiol Therapeutics, Inc. since 2019 and Chief Operating Officer & Director at Alterola Biotech, Inc. since 2021.
Former jobs include Chief Operating Officer & Director at Alterola Biotech, Inc. (California), Director at Protagenic Therapeutics, Inc. in 2025, Director-Scientific Affairs at GW Pharmaceuticals Ltd. from 2017 to 2019, Manager-Clinical Projects at Phytopharm Plc in 1999, Manager-Clinical Programme at Napp Pharmaceuticals Ltd. in 1990, and Chief Operating Officer at Alinova Biosciences Ltd. from 2019 to 2020.
Education includes undergraduate studies at Loughborough University.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
CARDIOL THERAPEUTICS INC. CLASS A 0.13%	03/12/2025	142,500 ( 0.13% )	173 850 $	31/05/2026

Colin Stott active positions

Companies	Position	Start
ALTEROLA BIOTECH, INC.	Chief Operating Officer	21/06/2021
CARDIOL THERAPEUTICS INC.	Director/Board Member	03/12/2019
Phytotherapeutix Holdings Ltd.	Chief Executive Officer	01/11/2020
Phytotherapeutix Ltd.	Chief Executive Officer	01/04/2019

All active positions of Colin Stott

Former positions of Colin Stott

Companies	Position	End
PROTAGENIC THERAPEUTICS, INC.	Chief Operating Officer	08/08/2025
Alinova Biosciences Ltd.	Chief Operating Officer	01/12/2020
GW PHARMACEUTICALS PLC	Corporate Officer/Principal	01/05/2019
Phytopharm Plc Phytopharm Plc Pharmaceuticals: MajorHealth Technology Engages in developing novel treatments targeting diseases	Corporate Officer/Principal	01/01/1999
Napp Pharmaceuticals Ltd. Napp Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and wholesales pharmaceutical products	Corporate Officer/Principal	02/01/1990

See the detail of Colin Stott's experience

Training of Colin Stott

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Colin Stott's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	11
Alterola Biotech, Inc. (California) Alterola Biotech, Inc. (California) Chemicals: SpecialtyProcess Industries Manufactures medicament containing chewing gums	Process Industries
Phytopharm Plc Phytopharm Plc Pharmaceuticals: MajorHealth Technology Engages in developing novel treatments targeting diseases	Health Technology
GW Pharmaceuticals Ltd. GW Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops and markets novel therapeutics	Health Technology
Napp Pharmaceuticals Ltd. Napp Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and wholesales pharmaceutical products	Health Technology
Loughborough University Loughborough University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Protagenic Therapeutics, Inc. Protagenic Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates biopharmaceutical company that engages in discovery and development of therapeutics to treat stress-related neuropsychiatric & mood disorders	Health Technology
Cardiol Therapeutics, Inc. Cardiol Therapeutics, Inc. BiotechnologyHealth Technology Operates as a life sciences company that researches and develops antifibrotic and anti-inflammatory therapy for the treatment of cardiovascular disease	Health Technology
Alinova Biosciences Ltd.
Alterola Biotech, Inc. Alterola Biotech, Inc. Pharmaceuticals: OtherHealth Technology Develops medical cannabis products	Health Technology
Phytotherapeutix Holdings Ltd.
Phytotherapeutix Ltd.